Atlas Trials

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

Clinical trial NCT02351505 · TERMINATED

Trial details

NCT number
NCT02351505
Sponsor
Erin Bertino
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Small Cell Lung Carcinoma
Start date
2015-05-01
Primary completion
2015-12-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.